Meetoo, D, Wong, L and Fatani, T 2017, 'Continuous subcutaneous insulin infusion in patients with type 1 disease' , British Journal of Healthcare Management, 23 (7) , pp. 313-318.
Full text not available from this repository. (Request a copy)Abstract
Optimal blood glucose control and the restoration of physiological insulin secretion is an ongoing medical challenge. Continuous subcutaneous insulin infusion (CSII) aims to restore blood glucose levels and reduce the frequency of hypoglycaemic events. Its benefits include a better glycaemic profile compared with management involving multiple daily insulin injections and giving individuals more flexibility in their everyday lives. The advantages of insulin pumps include basal delivery consistency, adjustable basal rates and low insulin depots. However, experience with CSII indicates that candidates should be selected carefully, be well educated in how use the device and be highly motivated to improve their blood glucose control.
| Item Type: | Article |
|---|---|
| Schools: | Schools > School of Health and Society |
| Journal or Publication Title: | British Journal of Healthcare Management |
| Publisher: | Mark Allen Group |
| ISSN: | 1358-0574 |
| Related URLs: | |
| SWORD Depositor: | Publications Router |
| Depositing User: | Publications Router |
| Date Deposited: | 30 Aug 2017 11:36 |
| Last Modified: | 27 Aug 2021 20:41 |
| URI: | https://usir.salford.ac.uk/id/eprint/43072 |
Actions (login required)
 |
Edit record (repository staff only) |
Tools
Tools